BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AKY-1189 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AKY-1189\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07020117-9040@assetmemo.bio
DTSTAMP:20261121T004540Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:AKY-1189: Phase 1 readout est. (NCT07020117)
DESCRIPTION:AKY-1189\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stud
 y of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors\nEstimated primary c
 ompletion: December 2027. This is a ClinicalTrials.gov estimate\, not a co
 nfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/
 drug/aky-1189#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07020117
URL:https://assetmemo.bio/drug/aky-1189#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
